DNYUZ
  • Home
  • News
    • U.S.
    • World
    • Politics
    • Opinion
    • Business
    • Crime
    • Education
    • Environment
    • Science
  • Entertainment
    • Culture
    • Music
    • Movie
    • Television
    • Theater
    • Gaming
    • Sports
  • Tech
    • Apps
    • Autos
    • Gear
    • Mobile
    • Startup
  • Lifestyle
    • Arts
    • Fashion
    • Food
    • Health
    • Travel
No Result
View All Result
DNYUZ
No Result
View All Result
Home Lifestyle Health

FDA approves blood test that can help diagnose Alzheimer’s disease

May 16, 2025
in Health, News
FDA approves blood test that can help diagnose Alzheimer’s disease
495
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

WASHINGTON — U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who may benefit from drugs that can modestly slow the memory-destroying disease.

The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties. The Food and Drug Administration cleared it for patients 55 and older who are showing early signs of the disease.

More than 6 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans.

The blood test identifies a sticky brain plaque that is a key marker for Alzheimer’s. AP

The lower costs and convenience of a blood test could also help expand use of two new drugs, Leqembi and Kisunla, which have been shown to slightly slow the progression of Alzheimer’s by clearing amyloid from the brain. Doctors are required to test patients for the plaque before prescribing the drugs, which require regular IV infusions.

“Today’s clearance is an important step for Alzheimer’s disease diagnosis, making it easier and potentially more accessible for U.S. patients earlier in the disease,” said Dr. Michelle Tarver, of FDA’s center for devices.

A number of specialty hospitals and laboratories have already developed their own in-house tests for amyloid in recent years. But those tests aren’t reviewed by the FDA and generally aren’t covered by insurance. Doctors have also had little data to judge which tests are reliable and accurate, leading to an unregulated marketplace that some have called a “wild west.”

Several larger diagnostic and drug companies are also developing their own tests for FDA approval, including Roche, Eli Lilly and C2N Diagnostics.

The tests can only be ordered by a doctor and aren’t intended for people who don’t yet have any symptoms.

The post FDA approves blood test that can help diagnose Alzheimer’s disease appeared first on New York Post.

Tags: alzheimer's diseaseblood testsFDA
Share198Tweet124Share
Pressure grows on Johnson to hold vote on military pay
News

Pressure grows on Johnson to hold vote on military pay

by WHNT
October 9, 2025

Pressure is rising on House Speaker Mike Johnson (R-La.) to call the House back in session for a vote on ...

Read more
News

Pastor Pepper-Sprayed by ICE Speaks Out on ‘Disturbing’ Incident

October 9, 2025
News

Taiwan’s president pledges to accelerate the building of air defense system in face of China threat

October 9, 2025
News

US Senate unanimously endorses repeal of 2002 Iraq war resolution

October 9, 2025
News

DOJ in Trouble After Lawyers Reposted Trump Rant on Luigi Mangione

October 9, 2025
Turning Point USA to offer ‘All American Halftime Show’ alternative to NFL’s woke Super Bowl spectacle

Turning Point USA to offer ‘All American Halftime Show’ alternative to NFL’s woke Super Bowl spectacle

October 9, 2025
Portugal’s local elections poised to be another win for Europe’s far right

Portugal’s local elections poised to be another win for Europe’s far right

October 9, 2025
‘Grey’s Anatomy’: EP Meg Marinis On Premiere’s Big Death (And Near Death), Season 22 Theme, Ellen Pompeo & Scott Speedman’s Presence And More

‘Grey’s Anatomy’: EP Meg Marinis On Premiere’s Big Death (And Near Death), Season 22 Theme, Ellen Pompeo & Scott Speedman’s Presence And More

October 9, 2025

Copyright © 2025.

No Result
View All Result
  • Home
  • News
    • U.S.
    • World
    • Politics
    • Opinion
    • Business
    • Crime
    • Education
    • Environment
    • Science
  • Entertainment
    • Culture
    • Gaming
    • Music
    • Movie
    • Sports
    • Television
    • Theater
  • Tech
    • Apps
    • Autos
    • Gear
    • Mobile
    • Startup
  • Lifestyle
    • Arts
    • Fashion
    • Food
    • Health
    • Travel

Copyright © 2025.